Call us Now! 604-222-9577


News Releases

Current News

  • Jun 172015

    The following surgeons have joined ARC’s Clinical Advisory Board:
    – Dr. Rudy De Wilde, PhD, ScD, MD. Dr. De Wilde is the Director of Ob/Gyn at Pius Hospital in Germany and a key opinion leader and principal investigator of adhesion clinical studies.
    – Dr. Brian Kwon, MD, FRCSC, PhD. Dr. Kwon is a surgeon-scientist who is an Associate Professor in the Department of Orthopaedics (UBC), the Associate Director, Clinical Research, for ICORD and the Associate Scientific Director of the Rick Hansen Institute.
    – Dr. Jian (James) Ye, MD, MSc, FRCSC. Dr. Ye is a cardiovascular surgeon, director of Clinical Research at St. Paul’s Hospital and a Clinical Professor of Surgery at UBC.

  • Jan 282015

    ARC successfully developed an animal spine (laminectomy) surgical adhesion model and showed compelling efficacy of fucoidan in preventing the formation of spinal adhesions in the spine model.

  • Jan 202015

    Fucoidan significantly reduced the formation of cardiac adhesions in an animal cardiac model.

  • Nov 12014

    ARC entered into an exclusive distribution and supply agreement with Vedco, Inc. for PERIDAN in the U.S. equine veterinary market.

  • Jul 312014

    ARC successfully developed an animal model for cardiac surgical adhesions.

  • Apr 252014

    Chris Springate was an invited speaker at Colorado State University College of Veterinary Medicine’s conference “Surgical Techniques & Management of the Acute Abdomen in the Horse” in April. Key equine surgeons from the U.S were there.

  • Sep 252013

    PERIDAN® equine veterinary product re-launched.

  • Jun 152013

    Champion racehorse, Paynter, miraculously returns to the races after celiotomy surgery (in Dec 2012) where PERIDAN® was used)

  • Apr 52013

    Newly published article highlighting the impact of adhesions relating to colon cancer surgery

  • Mar 282013

    The U.S. FDA Center for Veterinary Medicine designated our veterinary product, PERIDAN®, as a veterinary medical device. Bioniche Life Sciences Inc., our veterinary partner, is ramping up production along with marketing and sales for the U.S. market.

  • Dec 12012

    The use of PERIDAN® at the conclusion of a celiotomy surgery of the champion racehorse, Paynter

Archived News